Molecular Insight Pharmaceuticals Overview

  • Founded
  • 1998

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 71

Employees
  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 6

Molecular Insight Pharmaceuticals General Information

Description

Developer of small-molecule chemistry platform to significantly impact the care of men with prostate cancer. The company offers clinical stage specialty that are focused on critical unmet diagnostic and therapeutic needs of the prostate cancer patient.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Parent Company
Primary Office
  • 160 Second Street
  • Cambridge, MA 02142
  • United States
+1 (617) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Molecular Insight Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Molecular Insight Pharmaceuticals‘s full profile, request access.

Request a free trial

Molecular Insight Pharmaceuticals Patents

Molecular Insight Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-9956305-B2 Organ protection in psma-targeted radionuclide therapy of prostate cancer Active 08-Sep-2014 00000000000 00
EP-3193914-A1 Organ protection in psma-targeted radionuclide therapy of prostate cancer Granted 08-Sep-2014 00000000000
EP-3193914-B1 Organ protection in psma-targeted radionuclide therapy of prostate cancer Active 08-Sep-2014 00000000000
US-20160067361-A1 Organ protection in psma-targeted radionuclide therapy of prostate cancer Granted 08-Sep-2014 00000000000 0
US-20200254120-A1 Organ protection in psma-targeted radionuclide therapy of prostate cancer Granted 08-Sep-2014 A61K51/0497
To view Molecular Insight Pharmaceuticals’s complete patent history, request access »

Molecular Insight Pharmaceuticals Executive Team (10)

Name Title Board Seat Contact Info
Nelson Stacks Chief Executive Officer & Director
John Babich Ph.D Interim Chief Executive Officer & Chairman of the Board
Barry Frankel Director
You’re viewing 3 of 10 executive team members. Get the full list »

Molecular Insight Pharmaceuticals Board Members (5)

Name Representing Role Since
000000 000000 Self Board Member 000 0000
0000 000000 00.0 Molecular Insight Pharmaceuticals Interim Chief Executive Officer & Chairman of the Board 000 0000
000000 000000000 00 Self Board Member 000 0000
You’re viewing 3 of 5 board members. Get the full list »

Molecular Insight Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Molecular Insight Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Molecular Insight Pharmaceuticals‘s full profile, request access.

Request a free trial